Primary |
Hypertension |
69.0% |
Ill-defined Disorder |
4.0% |
Blood Cholesterol Increased |
3.5% |
Drug Use For Unknown Indication |
3.2% |
Diabetes Mellitus |
3.1% |
Blood Pressure |
2.3% |
Blood Pressure Abnormal |
2.1% |
Depression |
1.6% |
Cardiac Disorder |
1.6% |
Essential Hypertension |
1.2% |
Pain |
1.1% |
Hyperlipidaemia |
0.9% |
Arthritis |
0.9% |
Gastrooesophageal Reflux Disease |
0.9% |
Insomnia |
0.9% |
Hypercholesterolaemia |
0.8% |
Anxiety |
0.7% |
Blood Pressure Increased |
0.7% |
Hypothyroidism |
0.7% |
Supplementation Therapy |
0.7% |
|
Death |
21.0% |
Oedema Peripheral |
12.3% |
Drug Hypersensitivity |
6.6% |
Drug Ineffective |
6.6% |
Hypertension |
5.8% |
Blood Pressure Inadequately Controlled |
5.1% |
Cerebrovascular Accident |
3.4% |
Weight Decreased |
3.4% |
Headache |
3.4% |
Malaise |
3.3% |
Rash |
3.2% |
Suicide Attempt |
3.2% |
Blood Pressure Increased |
3.0% |
Dizziness |
3.0% |
Myocardial Infarction |
2.9% |
Oedema |
2.9% |
Swelling |
2.9% |
Weight Increased |
2.8% |
Pain In Extremity |
2.7% |
Joint Swelling |
2.6% |
|
Secondary |
Hypertension |
39.7% |
Product Used For Unknown Indication |
17.4% |
Drug Use For Unknown Indication |
8.7% |
Diabetes Mellitus |
4.0% |
Depression |
3.7% |
Blood Cholesterol Increased |
3.3% |
Anxiety |
2.4% |
Cardiac Disorder |
2.2% |
Convulsion |
2.1% |
Lower Limb Fracture |
1.7% |
Spinal Fracture |
1.7% |
Pain |
1.7% |
Blood Pressure |
1.7% |
Type 2 Diabetes Mellitus |
1.7% |
Chronic Obstructive Pulmonary Disease |
1.6% |
Arthritis |
1.4% |
Osteoporosis |
1.3% |
Musculoskeletal Pain |
1.3% |
Insomnia |
1.3% |
Angina Pectoris |
1.3% |
|
Death |
11.0% |
Oedema Peripheral |
8.1% |
Vomiting |
6.4% |
Hypertension |
6.2% |
Weight Decreased |
5.9% |
Malaise |
5.8% |
Weight Increased |
5.2% |
Myocardial Infarction |
5.0% |
Headache |
4.7% |
Syncope |
4.6% |
Toxic Epidermal Necrolysis |
4.5% |
Cerebrovascular Accident |
4.2% |
Rash |
4.1% |
Drug Ineffective |
3.9% |
Loss Of Consciousness |
3.8% |
Pain |
3.6% |
Hypotension |
3.3% |
Pain In Extremity |
3.3% |
Suicide Attempt |
3.2% |
Interstitial Lung Disease |
3.0% |
|
Concomitant |
Hypertension |
24.1% |
Product Used For Unknown Indication |
21.4% |
Drug Use For Unknown Indication |
14.5% |
Rheumatoid Arthritis |
4.5% |
Diabetes Mellitus |
4.3% |
Prophylaxis |
3.6% |
Pain |
3.6% |
Depression |
2.7% |
Osteoporosis |
2.5% |
Blood Cholesterol Increased |
2.0% |
Blood Pressure |
1.9% |
Type 2 Diabetes Mellitus |
1.8% |
Multiple Myeloma |
1.8% |
Gastrooesophageal Reflux Disease |
1.8% |
Asthma |
1.6% |
Constipation |
1.6% |
Insomnia |
1.6% |
Hepatitis C |
1.5% |
Atrial Fibrillation |
1.5% |
Chronic Obstructive Pulmonary Disease |
1.5% |
|
Vomiting |
12.9% |
Weight Decreased |
9.4% |
Weight Increased |
6.5% |
Myocardial Infarction |
5.9% |
Pneumonia |
5.7% |
Nausea |
5.1% |
Drug Ineffective |
4.9% |
Urinary Tract Infection |
4.7% |
Death |
4.6% |
Pain |
4.5% |
Pyrexia |
4.1% |
Rash |
4.1% |
Renal Failure Acute |
3.9% |
Renal Failure |
3.8% |
White Blood Cell Count Decreased |
3.7% |
Vision Blurred |
3.5% |
Oedema Peripheral |
3.4% |
Dyspnoea |
3.3% |
Pain In Extremity |
3.1% |
Thrombocytopenia |
3.0% |
|
Interacting |
Hypertension |
37.5% |
Acute Coronary Syndrome |
6.8% |
Convulsion |
6.3% |
Blood Pressure Abnormal |
5.8% |
Hypertensive Heart Disease |
4.8% |
Diabetes Mellitus |
4.4% |
Cardiac Disorder |
3.9% |
Ingrowing Nail |
3.6% |
Pain |
3.1% |
Renal Disorder |
2.7% |
Cardiac Failure Congestive |
2.4% |
Hiv Infection |
2.4% |
Angina Pectoris |
2.2% |
Flushing |
2.2% |
Heart Rate Abnormal |
2.2% |
Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
Depression |
1.9% |
Product Used For Unknown Indication |
1.9% |
Urine Abnormality |
1.9% |
Agitation |
1.7% |
|
Drug Interaction |
20.5% |
Loss Of Consciousness |
8.0% |
Headache |
6.8% |
Hepatitis Cholestatic |
6.8% |
Hypertension |
6.8% |
Hypertensive Crisis |
5.7% |
Renal Failure Acute |
4.5% |
Wound |
4.5% |
Dizziness |
3.4% |
Drug Ineffective |
3.4% |
Lung Disorder |
3.4% |
Palpitations |
3.4% |
Syncope |
3.4% |
Tachycardia |
3.4% |
Ventricular Fibrillation |
3.4% |
Vomiting |
3.4% |
Faeces Discoloured |
2.3% |
Heart Rate Decreased |
2.3% |
Pancreatitis |
2.3% |
Potentiating Drug Interaction |
2.3% |
|